Clinical trials sponsored by Tang-Du Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Tang-Du Hospital

• Adebrelimab + Apatinib in SCLC Maintenance Therapy
  NCT06475209 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
  NCT07141264 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Assessment of Brain Cognitive Impairment in Breast Cancer
  NCT05305092 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial
  NCT06485544 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
  NCT07354061 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
  NCT06644066 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
  NCT06864624 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%
  NCT07596121 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• The Early Warning System for the Diabetic Encephalopathy
  NCT02420470 · Phase: Not specified · Ages: 40 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Tang-Du Hospital recruiting for?

Tang-Du Hospital is the lead sponsor of 9 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.